Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.


ratings:
Length:
48 minutes
Released:
Nov 13, 2020
Format:
Podcast episode

Description

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stefan Beyer, President and Managing Director at Vibalogics and Tom Hochuli, Chief Executive Officer at Vibalogics. Who is this dynamic duo you ask? Stefan has spent the bulk of his career in the vaccines and biologics space. He has been head of Vibalogics for almost 13 years, steering the company from a local startup, to global CDMO and world leader in the production of virotherapy products and oncolytic vaccines. Tom has over 25 years experience in the sector and prior to Vibalogics, he headed the cell and gene therapy operations for Lonza Houston. Today, Tom is responsible for Vibalogics’ U.S. expansion plans as the company sets its sights on developing a late phase and commercial virus manufacturing facility on the East Coast, U.S.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guests Stefan and Tom, covering the boom in virotherapy capabilities such as oncolytic viruses, viral vector gene therapies and viral vector vaccines over the past decade. Tom discusses the lessons he’s learned from being a platoon leader in the US Army to leading teams in business. Tom and Stefan explain how as a leader, it is important to have an open mind when it comes to exploring new opportunities and ideas and accepting failure as a part of success and learning. Lastly we explore the short-term impact that Covid-19 has had on delaying promising pipelines and compounds currently in clinical trials. We look ahead to the longer-term impact it will have on refocusing drug developers’ attention on the need for vaccines, and being better prepared in the case of an infectious outbreak. 
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.
Released:
Nov 13, 2020
Format:
Podcast episode

Titles in the series (100)

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.